Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Korro Bio, Inc. Common Stock, par value $0.001 per share (KRRO).
- Disclosed ownership: 5.7%.
- Date of event: 10 Mar 2026.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5.7% ownership in Korro Bio, Inc. Common Stock, par value $0.001 per share (KRRO) on 10 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 3.7% | 540,054 | 0 | 540,054 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 3.7% | 540,054 | 0 | 540,054 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Biotech Private Investments, LLC | 1.9% | 276,831 | 0 | 276,831 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| Differentiated Ventures Investments, LLC | 1.9% | 276,831 | 0 | 276,831 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| 72 Investment Holdings, LLC | 1.9% | 276,831 | 0 | 276,831 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5.7% | 816,885 | 0 | 816,885 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |